Skip to main content
Premium Trial:

Request an Annual Quote

Saladax, CESAR Partner on Study of 5-FU Dosing for Colorectal Cancer

NEW YORK (GenomeWeb News) – Saladax Biomedical announced today a collaborative study of metastatic colorectal cancer patients treated with 5-fluorouracil, or 5-FU, and whose doses will be optimized based on actual 5-FU blood levels.

As part of the collaboration with the Central European Society for Anticancer Drug Research, or CESAR, Saladax's My5-FU immunoassay technology will be used to measure 5-FU levels.

CESAR is sponsoring the single-arm study, which is designed "to determine whether target blood levels of 5-FU can be maintained during the course of treatment by optimizing the dose administered to individual patients at each infusion," the Bethlehem, Penn.-based company said in a statement. The two partners aim to achieve a stable target blood level of the chemotherapeutic and investigate whether this dose optimization can reduce 5-FU-related toxicities.

Financial and other terms of the deal were not disclosed.

The study, which involves four centers and will enroll 80 patients with metastatic colorectal cancer, is expected to last one year. Patients will remain in the study until a total of six doses of 5-FU treatment has been administered and the end-of-treatment visit has been conducted, Saladax said.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.